{"DataElement":{"publicId":"14007920","version":"1","preferredName":"Pharmacologic Substance Administered Dose Type","preferredDefinition":"A description of the pharmacologic substance dose that was administered.","longName":"PHARM_SUB_ADMIN_DS_TP","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"3178363","version":"1","preferredName":"Pharmacologic Substance Administered","preferredDefinition":"An active natural, synthetic or semi-synthetic ingredient including endogenous body substance that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease or to affect the structure or any function of the human body, but does not include intermediates used in the synthesis of such ingredient (21 CFR 314.3(b))._Given.","longName":"2437803v1.0:2233610v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2437803","version":"1","preferredName":"Pharmacologic Substance","preferredDefinition":"A natural, synthetic or semi-synthetic substance including endogenous body substance used to diagnose, prevent, maintain, treat or analyze abnormal and normal biological functions in vivo or in vitro.","longName":"C1909","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pharmacologic Substance","conceptCode":"C1909","definition":"Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07F9D768-37A3-6CA7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-15","endDate":null,"createdBy":"UMLLOADER_CAMOD","dateCreated":"2005-12-15","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233610","version":"1","preferredName":"Administered","preferredDefinition":"Given.","longName":"C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D864-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"986794D5-8636-81A4-E040-BB89AD431F81","latestVersionIndicator":"Yes","beginDate":"2010-12-27","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-27","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Curated for The Cancer Genome Atlas (TCGA) by request of T. Lichtenberg 12/2010 sw","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"14007916","version":"1","preferredName":"Dose Administered Type","preferredDefinition":"A quantity of an agent given to an individual at one time._Something distinguishable as an identifiable class based on common qualities.","longName":"14007916v1.00","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"25,000 IU/m2 IM or IV three days per week x 6 doses","valueDescription":null,"ValueMeaning":{"publicId":"14007917","version":"1","preferredName":"25,000 IU/m2 IM or IV three days per week x 6 doses","longName":"14007917v1.00","preferredDefinition":"25,000 IU/m2 IM or IV three days per week x 6 doses","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF375E26-20F6-346B-E053-731AD00AE985","latestVersionIndicator":"Yes","beginDate":"2023-06-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-06-28","modifiedBy":"KUMMEROA","dateModified":"2023-06-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF375E26-20F9-346B-E053-731AD00AE985","beginDate":"2023-06-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-06-28","modifiedBy":"KUMMEROA","dateModified":"2023-06-28","deletedIndicator":"No"},{"value":"25 mg/m2 IM two days per week (Mon/Wed) and 50 mg/m2 IM one day per week (Fri) x 6 doses","valueDescription":null,"ValueMeaning":{"publicId":"14007918","version":"1","preferredName":"25 mg/m2 IM two days per week (Mon/Wed) and 50 mg/m2 IM one day per week (Fri) x 6 doses","longName":"14007918v1.00","preferredDefinition":"25 mg/m2 IM two days per week (Mon/Wed) and 50 mg/m2 IM one day per week (Fri) x 6 doses","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF375E26-20F7-346B-E053-731AD00AE985","latestVersionIndicator":"Yes","beginDate":"2023-06-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-06-28","modifiedBy":"KUMMEROA","dateModified":"2023-06-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF375E26-20FA-346B-E053-731AD00AE985","beginDate":"2023-06-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-06-28","modifiedBy":"KUMMEROA","dateModified":"2023-06-28","deletedIndicator":"No"},{"value":"25 mg/m2 IM every 48 hours x 7 doses","valueDescription":null,"ValueMeaning":{"publicId":"14007919","version":"1","preferredName":"25 mg/m2 IM every 48 hours x 7 doses","longName":"14007919v1.00","preferredDefinition":"25 mg/m2 IM every 48 hours x 7 doses","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF375E26-20F8-346B-E053-731AD00AE985","latestVersionIndicator":"Yes","beginDate":"2023-06-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-06-28","modifiedBy":"KUMMEROA","dateModified":"2023-06-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF375E26-20FB-346B-E053-731AD00AE985","beginDate":"2023-06-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-06-28","modifiedBy":"KUMMEROA","dateModified":"2023-06-28","deletedIndicator":"No"},{"value":"Other","valueDescription":null,"ValueMeaning":{"publicId":"6431768","version":"1","preferredName":"Other","longName":"6431768v1.00","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"762A692A-EEF7-29A1-E053-F662850A9EA9","latestVersionIndicator":"Yes","beginDate":"2018-09-18","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-09-18","modifiedBy":"GDEEN","dateModified":"2024-01-22","changeDescription":null,"administrativeNotes":"2023.2.1 Alt VM added per ticket request CADSR0001995. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF375E26-20FC-346B-E053-731AD00AE985","beginDate":"2023-06-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-06-28","modifiedBy":"KUMMEROA","dateModified":"2023-06-28","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008560","version":"1","preferredName":"Therapy Doses","preferredDefinition":"quantities of therapy or treatment.","longName":"TX_DOSES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B30C55B6-50B5-1219-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"14007915","version":"1","preferredName":"Dose Administered Type","preferredDefinition":"A quantity of an agent given to an individual at one time._Something distinguishable as an identifiable class based on common qualities.","longName":"14007915v1.00","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dose Administered","conceptCode":"C167190","definition":"A quantity of an agent given to an individual at one time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF3749C0-DFC3-328D-E053-731AD00AAC34","latestVersionIndicator":"Yes","beginDate":"2023-06-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-06-28","modifiedBy":"KUMMEROA","dateModified":"2023-06-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF3749C0-DFC4-328D-E053-731AD00AAC34","latestVersionIndicator":"Yes","beginDate":"2023-06-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-06-28","modifiedBy":"KUMMEROA","dateModified":"2023-09-12","changeDescription":null,"administrativeNotes":"20213.9.12 Released per review. ak 2023.6.28 Created per ticket request CADSR0002550. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"AGT_DLVRD_DOSED","type":"COG Form Element","context":"COG"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"What was the pharmacologic substance dose administered?","url":null,"context":"COG"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"If Asparaginase Erwinia Chrysanthemi (Erwinaze) was delivered, how was it dosed?","url":null,"context":"COG"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"If Asparaginase Erwinia Chrysanthemi Recombinant (Rylaze) was delivered, how was it dosed?","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF3771CD-3765-39BE-E053-731AD00A5A41","latestVersionIndicator":"Yes","beginDate":"2023-06-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-06-28","modifiedBy":"KUMMEROA","dateModified":"2023-09-12","changeDescription":null,"administrativeNotes":"2023.9.12 Released per metrics report. ak2023.6.28 Created per ticket request CADSR0002550. ak","unresolvedIssues":null,"deletedIndicator":"No"}}